Skip to main content
Top
Published in: BMC Public Health 1/2009

Open Access 01-12-2009 | Research article

The impact of demographic and risk factor changes on coronary heart disease deaths in Beijing, 1999–2010

Authors: Jun Cheng, Dong Zhao, Zhechun Zeng, Julia Alison Critchley, Jing Liu, Wei Wang, Jiayi Sun, Simon Capewell

Published in: BMC Public Health | Issue 1/2009

Login to get access

Abstract

Background

Recent, dramatic increases in coronary heart disease (CHD) mortality in China can be mostly explained by adverse changes in major cardiovascular risk factors. Our study aimed to assess the potential impact of subsequent changes in risk factors and population ageing on CHD deaths in Beijing between 1999 and 2010.

Methods

The previously validated IMPACT model was used to estimate the CHD deaths expected in 2010, with treatment uptakes being held constant at levels measured in 1999, comparing three scenarios: a) taking into account the ageing of the population but assuming no further changes in major risk factor levels from 1999 or, b) if recent risk factor trends continued until 2010 or, c) if there was a 0.5% annual reduction in each risk factor.

Results

Population ageing alone would result in approximately 1990 additional deaths in 2010 compared with 1999, representing an increase of 27%. Continuation of current risk factor trends would result in approximately 3,015 extra deaths in 2010, [a 40% increase]; three quarters of this increase would be attributable to rises in total cholesterol levels. Thus, demographic changes and worsening risk factors would together result in a 67% increase in CHD deaths. Conversely, assumed 0.5% annual reductions in risk factors (a mean population level decline of 0.3 mmol/L for total cholesterol in both genders, and smoking prevalence declining by 3.0% for men and 4.1% for women, body mass index by 1.3 kg/m2 for men and 1.4 kg/m2 for women, diabetes prevalence by 0.4% in both genders, and diastolic blood pressure by 4.7 mmHg for men and 4.4 mmHg for women) would result in some 3,730 fewer deaths, representing a 23% decrease overall. These findings remained consistent in sensitivity analyses.

Conclusion

CHD death rates are continuing to rise in Beijing. This reflects worsening risk factor levels, compounded by demographic trends. However, the adverse impact of population ageing on CHD burden could be completely offset by eminently feasible improvements in diet and smoking.
Appendix
Available only for authorised users
Literature
1.
go back to reference Tunstall-Pedoe H, Kuulasmaa K, Mahonen M, Tolonen H, Ruokokoski E, Amouyel P: Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. Lancet. 1999, 353: 1547-1557. 10.1016/S0140-6736(99)04021-0.CrossRefPubMed Tunstall-Pedoe H, Kuulasmaa K, Mahonen M, Tolonen H, Ruokokoski E, Amouyel P: Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. Lancet. 1999, 353: 1547-1557. 10.1016/S0140-6736(99)04021-0.CrossRefPubMed
2.
go back to reference Beaglehole R: Global cardiovascular disease prevention: time to get serious. Lancet. 2001, 358: 661-663. 10.1016/S0140-6736(01)05784-1.CrossRefPubMed Beaglehole R: Global cardiovascular disease prevention: time to get serious. Lancet. 2001, 358: 661-663. 10.1016/S0140-6736(01)05784-1.CrossRefPubMed
3.
go back to reference Murray CJ, Lopez AD: Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet. 1997, 349: 1269-1276. 10.1016/S0140-6736(96)07493-4.CrossRefPubMed Murray CJ, Lopez AD: Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet. 1997, 349: 1269-1276. 10.1016/S0140-6736(96)07493-4.CrossRefPubMed
4.
go back to reference Weinstein MC, Coxson PG, Williams LW, Pass TM, Stason WB, Goldman L: Forecasting coronary heart disease incidence, mortality, and cost: the Coronary Heart Disease Policy Model. Am J Public Health. 1987, 77: 1417-1426. 10.2105/AJPH.77.11.1417.CrossRefPubMedPubMedCentral Weinstein MC, Coxson PG, Williams LW, Pass TM, Stason WB, Goldman L: Forecasting coronary heart disease incidence, mortality, and cost: the Coronary Heart Disease Policy Model. Am J Public Health. 1987, 77: 1417-1426. 10.2105/AJPH.77.11.1417.CrossRefPubMedPubMedCentral
5.
go back to reference Critchley JA, Capewell S: Why model coronary heart disease?. Eur Heart J. 2002, 23: 110-116. 10.1053/euhj.2001.2681.CrossRefPubMed Critchley JA, Capewell S: Why model coronary heart disease?. Eur Heart J. 2002, 23: 110-116. 10.1053/euhj.2001.2681.CrossRefPubMed
6.
7.
go back to reference Hunink MG, Goldman L, Tosteson AN, Mittleman MA, Goldman PA, Williams LW, Tsevat J, Weinstein MC: The recent decline in mortality from coronary heart disease, 1980–1990. The effect of secular trends in risk factors and treatment. JAMA. 1997, 277: 535-542. 10.1001/jama.277.7.535.CrossRefPubMed Hunink MG, Goldman L, Tosteson AN, Mittleman MA, Goldman PA, Williams LW, Tsevat J, Weinstein MC: The recent decline in mortality from coronary heart disease, 1980–1990. The effect of secular trends in risk factors and treatment. JAMA. 1997, 277: 535-542. 10.1001/jama.277.7.535.CrossRefPubMed
9.
go back to reference Capewell S, Beaglehole R, Seddon M, McMurray J: Explanation for the decline in coronary heart disease mortality rates in Auckland, New Zealand, between 1982 and 1993. Circulation. 2000, 102: 1511-1516.CrossRefPubMed Capewell S, Beaglehole R, Seddon M, McMurray J: Explanation for the decline in coronary heart disease mortality rates in Auckland, New Zealand, between 1982 and 1993. Circulation. 2000, 102: 1511-1516.CrossRefPubMed
10.
go back to reference Capewell S, Morrison CE, McMurray JJ: Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994. Heart. 1999, 81: 380-386.CrossRefPubMedPubMedCentral Capewell S, Morrison CE, McMurray JJ: Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994. Heart. 1999, 81: 380-386.CrossRefPubMedPubMedCentral
11.
go back to reference Unal B, Critchley JA, Capewell S: Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000. Circulation. 2004, 109: 1101-1107. 10.1161/01.CIR.0000118498.35499.B2.CrossRefPubMed Unal B, Critchley JA, Capewell S: Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000. Circulation. 2004, 109: 1101-1107. 10.1161/01.CIR.0000118498.35499.B2.CrossRefPubMed
12.
go back to reference Bennett K, Kabir Z, Unal B, Shelley E, Critchley J, Perry I, Feely J, Capewell S: Explaining the recent decrease in coronary heart disease mortality rates in Ireland, 1985–2000. J Epidemiol Community Health. 2006, 60: 322-327. 10.1136/jech.2005.038638.CrossRefPubMedPubMedCentral Bennett K, Kabir Z, Unal B, Shelley E, Critchley J, Perry I, Feely J, Capewell S: Explaining the recent decrease in coronary heart disease mortality rates in Ireland, 1985–2000. J Epidemiol Community Health. 2006, 60: 322-327. 10.1136/jech.2005.038638.CrossRefPubMedPubMedCentral
13.
go back to reference Laatikainen T, Critchley J, Vartiainen E, Salomaa V, Ketonen M, Capewell S: Explaining the decline in coronary heart disease mortality in Finland between 1982 and 1997. Am J Epidemiol. 2005, 162: 764-773. 10.1093/aje/kwi274.CrossRefPubMed Laatikainen T, Critchley J, Vartiainen E, Salomaa V, Ketonen M, Capewell S: Explaining the decline in coronary heart disease mortality in Finland between 1982 and 1997. Am J Epidemiol. 2005, 162: 764-773. 10.1093/aje/kwi274.CrossRefPubMed
14.
go back to reference Goldman L, Cook EF: The decline in ischemic heart disease mortality rates. An analysis of the comparative effects of medical interventions and changes in lifestyle. Ann Intern Med. 1984, 101: 825-836.CrossRefPubMed Goldman L, Cook EF: The decline in ischemic heart disease mortality rates. An analysis of the comparative effects of medical interventions and changes in lifestyle. Ann Intern Med. 1984, 101: 825-836.CrossRefPubMed
15.
go back to reference Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR, Kottke TE, Giles WH, Capewell S: Explaining the decrease in U.S. deaths from coronary disease, 1980–2000. N Engl J Med. 2007, 356: 2388-2398. 10.1056/NEJMsa053935.CrossRefPubMed Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR, Kottke TE, Giles WH, Capewell S: Explaining the decrease in U.S. deaths from coronary disease, 1980–2000. N Engl J Med. 2007, 356: 2388-2398. 10.1056/NEJMsa053935.CrossRefPubMed
16.
go back to reference Critchley J, Capewell S: Substantial potential for reductions in coronary heart disease mortality in the UK through changes in risk factor levels. J Epidemiol Community Health. 2003, 57: 243-247. 10.1136/jech.57.4.243.CrossRefPubMedPubMedCentral Critchley J, Capewell S: Substantial potential for reductions in coronary heart disease mortality in the UK through changes in risk factor levels. J Epidemiol Community Health. 2003, 57: 243-247. 10.1136/jech.57.4.243.CrossRefPubMedPubMedCentral
17.
go back to reference Aslan BU, Critchley JA, Capewell S: Small changes in UK cardiovascular risk factors could halve coronary heart disease mortality. J Clin Epidemiol. 2005, 58: 733-740. 10.1016/j.jclinepi.2004.09.015.CrossRef Aslan BU, Critchley JA, Capewell S: Small changes in UK cardiovascular risk factors could halve coronary heart disease mortality. J Clin Epidemiol. 2005, 58: 733-740. 10.1016/j.jclinepi.2004.09.015.CrossRef
18.
go back to reference Critchley J, Liu J, Zhao D, Wang W, Capewell S: Explaining the increase in coronary heart disease mortality in Beijing between 1984 and 1999. Circulation. 2004, 110: 1236-1244. 10.1161/01.CIR.0000140668.91896.AE.CrossRefPubMed Critchley J, Liu J, Zhao D, Wang W, Capewell S: Explaining the increase in coronary heart disease mortality in Beijing between 1984 and 1999. Circulation. 2004, 110: 1236-1244. 10.1161/01.CIR.0000140668.91896.AE.CrossRefPubMed
20.
go back to reference Wu ZS, Yao CH, Zhao D, Wu GX, Wang W, Liu J, Zeng ZC, Wu YK: Sino-MONICA Project: A collaborative study on trends and determinants in cardiovascular diseases in China, Part I: morbidity and mortality monitoring. Circulation. 2001, 103: 462-468. 10.1161/hc2301.091931.CrossRefPubMed Wu ZS, Yao CH, Zhao D, Wu GX, Wang W, Liu J, Zeng ZC, Wu YK: Sino-MONICA Project: A collaborative study on trends and determinants in cardiovascular diseases in China, Part I: morbidity and mortality monitoring. Circulation. 2001, 103: 462-468. 10.1161/hc2301.091931.CrossRefPubMed
21.
go back to reference Wu ZS, Yao CH, Zhao D: Sino-MONICA II: the results of survey for risk factors of cardiovascular disease. Chin J Cardiol. 1997, 25: 255-259. Wu ZS, Yao CH, Zhao D: Sino-MONICA II: the results of survey for risk factors of cardiovascular disease. Chin J Cardiol. 1997, 25: 255-259.
22.
go back to reference Liu J, Zhao D, Yao CH, Wu GX, Wang W, Zeng ZC, Wu ZS: Trends in CVD risk factors in urban and rural areas of Beijing during 1984–1993. Chin J Cardiol. 2000, 28: 308-311. Liu J, Zhao D, Yao CH, Wu GX, Wang W, Zeng ZC, Wu ZS: Trends in CVD risk factors in urban and rural areas of Beijing during 1984–1993. Chin J Cardiol. 2000, 28: 308-311.
23.
go back to reference Law MR, Wald NJ, Thompson SG: By how and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?. BMJ. 1994, 308: 367-372.CrossRefPubMedPubMedCentral Law MR, Wald NJ, Thompson SG: By how and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?. BMJ. 1994, 308: 367-372.CrossRefPubMedPubMedCentral
25.
go back to reference Asia Pacific Cohort Studies Collaboration: Body mass index and cardiovascular disease in the Asia-Pacific Region: an overview of 33 cohorts involving 310 000 participants. Int J Epidemiol. 2004, 33: 751-758. 10.1093/ije/dyh163.CrossRef Asia Pacific Cohort Studies Collaboration: Body mass index and cardiovascular disease in the Asia-Pacific Region: an overview of 33 cohorts involving 310 000 participants. Int J Epidemiol. 2004, 33: 751-758. 10.1093/ije/dyh163.CrossRef
26.
go back to reference Lewington S, Clarke R, Qizilbash N, Peto R, Collins R, for the Prospective Studies Collaboration: Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002, 360: 1903-1912. 10.1016/S0140-6736(02)11911-8.CrossRefPubMed Lewington S, Clarke R, Qizilbash N, Peto R, Collins R, for the Prospective Studies Collaboration: Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002, 360: 1903-1912. 10.1016/S0140-6736(02)11911-8.CrossRefPubMed
27.
go back to reference Chen ZM, Xu Z, Collins R, Li WX, Peto R: Early health effects of the emerging tobacco epidemic in China. JAMA. 1997, 278: 1500-1504. 10.1001/jama.278.18.1500.CrossRefPubMed Chen ZM, Xu Z, Collins R, Li WX, Peto R: Early health effects of the emerging tobacco epidemic in China. JAMA. 1997, 278: 1500-1504. 10.1001/jama.278.18.1500.CrossRefPubMed
28.
go back to reference Yuan JM, Ross RK, Wang XL, Gao YT, Henderson BE, Yu MC: Morbidity and mortality in relation to cigarette smoking in Shanghai, China: a prospective male cohort study. JAMA. 1996, 275: 1646-1650. 10.1001/jama.275.21.1646.CrossRefPubMed Yuan JM, Ross RK, Wang XL, Gao YT, Henderson BE, Yu MC: Morbidity and mortality in relation to cigarette smoking in Shanghai, China: a prospective male cohort study. JAMA. 1996, 275: 1646-1650. 10.1001/jama.275.21.1646.CrossRefPubMed
29.
go back to reference Nesto R: CHD: a major burden in type 2 diabetes. Acta Diabetol. 2001, 38: S3-S8. 10.1007/s005920170002.CrossRefPubMed Nesto R: CHD: a major burden in type 2 diabetes. Acta Diabetol. 2001, 38: S3-S8. 10.1007/s005920170002.CrossRefPubMed
30.
go back to reference Keen H, Clark C, Laakso M: Reducing the burden of diabetes: managing cardiovascular disease. Diabetes Metab Res Rev. 1999, 15: 186-196. 10.1002/(SICI)1520-7560(199905/06)15:3<186::AID-DMRR30>3.0.CO;2-5.CrossRefPubMed Keen H, Clark C, Laakso M: Reducing the burden of diabetes: managing cardiovascular disease. Diabetes Metab Res Rev. 1999, 15: 186-196. 10.1002/(SICI)1520-7560(199905/06)15:3<186::AID-DMRR30>3.0.CO;2-5.CrossRefPubMed
31.
go back to reference Zatonski WA, Willett W: Changes in dietary fat and declining coronary heart disease in Poland: population based study. BMJ. 2005, 331: 187-188. 10.1136/bmj.331.7510.187.CrossRefPubMedPubMedCentral Zatonski WA, Willett W: Changes in dietary fat and declining coronary heart disease in Poland: population based study. BMJ. 2005, 331: 187-188. 10.1136/bmj.331.7510.187.CrossRefPubMedPubMedCentral
32.
go back to reference Lee ET, Cowan LD, Welty TK, Sievers M, Howard WJ, Oopik A, Wang WY, Yeh J, Devereux RB, Rhoades ER, Fabsitz RR, Go O, Howard BV: All-cause morality and cardiovascular disease mortality in three American Indian populations, aged 45–74 years, 1984–1988: The Strong Heart Study. Am J Epidemiol. 1998, 147: 995-1008.CrossRefPubMed Lee ET, Cowan LD, Welty TK, Sievers M, Howard WJ, Oopik A, Wang WY, Yeh J, Devereux RB, Rhoades ER, Fabsitz RR, Go O, Howard BV: All-cause morality and cardiovascular disease mortality in three American Indian populations, aged 45–74 years, 1984–1988: The Strong Heart Study. Am J Epidemiol. 1998, 147: 995-1008.CrossRefPubMed
33.
go back to reference He J, Gu DF, Wu XG, Reynolds K, Duan XF, Yao CH, Wang JL, Chen CS, Chen J, Wildman RP, Klag MJ, Whelton PK: Major causes of death among men and women in China. N Engl J Med. 2005, 353: 1124-1134. 10.1056/NEJMsa050467.CrossRefPubMed He J, Gu DF, Wu XG, Reynolds K, Duan XF, Yao CH, Wang JL, Chen CS, Chen J, Wildman RP, Klag MJ, Whelton PK: Major causes of death among men and women in China. N Engl J Med. 2005, 353: 1124-1134. 10.1056/NEJMsa050467.CrossRefPubMed
35.
go back to reference Dwyer T, Emmanuel SC, Janus ED, Wu Z, Hynes KL, Zhang C: The emergence of coronary heart disease in populations of Chinese descent. Atherosclerosis. 2003, 167: 303-310. 10.1016/S0021-9150(03)00008-X.CrossRefPubMed Dwyer T, Emmanuel SC, Janus ED, Wu Z, Hynes KL, Zhang C: The emergence of coronary heart disease in populations of Chinese descent. Atherosclerosis. 2003, 167: 303-310. 10.1016/S0021-9150(03)00008-X.CrossRefPubMed
36.
go back to reference Okayama A, Ueshima H, Marmot M, Nakamura M, Kita Y, Yamakawa M: Changes in total serum cholesterol and other risk factors for cardiovascular disease in Japan, 1980–1989. Int J Epidemiol. 1993, 22: 1038-1047. 10.1093/ije/22.6.1038.CrossRefPubMed Okayama A, Ueshima H, Marmot M, Nakamura M, Kita Y, Yamakawa M: Changes in total serum cholesterol and other risk factors for cardiovascular disease in Japan, 1980–1989. Int J Epidemiol. 1993, 22: 1038-1047. 10.1093/ije/22.6.1038.CrossRefPubMed
37.
go back to reference Zhou BF: Chinese dietary pattern and features of cardiovascular disease 2002. proceedings of 2nd Five-Continent International Symposium on Cardiovascular Disease: 19–22. 2002, September ; Beijing, China Zhou BF: Chinese dietary pattern and features of cardiovascular disease 2002. proceedings of 2nd Five-Continent International Symposium on Cardiovascular Disease: 19–22. 2002, September ; Beijing, China
38.
go back to reference Kuulasmaa K, Tunstall-Pedoe H, Dobson A, Fortmann S, Sans S, Tolonen H, Evans A, Ferrario M, Tuomilehto J: Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet. 2000, 355: 675-687. 10.1016/S0140-6736(99)11180-2.CrossRefPubMed Kuulasmaa K, Tunstall-Pedoe H, Dobson A, Fortmann S, Sans S, Tolonen H, Evans A, Ferrario M, Tuomilehto J: Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet. 2000, 355: 675-687. 10.1016/S0140-6736(99)11180-2.CrossRefPubMed
39.
go back to reference Gu DF, Reynolds K, Wu XG, Chen J, Duan XF, Muntner P, Huang GY, Reynolds RF, Su SY, Whelton PK, He J: Prevalence, awareness, treatment, and control of hypertension in China. Hypertension. 2002, 40: 920-927. 10.1161/01.HYP.0000040263.94619.D5.CrossRefPubMed Gu DF, Reynolds K, Wu XG, Chen J, Duan XF, Muntner P, Huang GY, Reynolds RF, Su SY, Whelton PK, He J: Prevalence, awareness, treatment, and control of hypertension in China. Hypertension. 2002, 40: 920-927. 10.1161/01.HYP.0000040263.94619.D5.CrossRefPubMed
40.
go back to reference Yang GH, Ma JM, Liu N, Zhou LN: Smoking and passive smoking in Chinese, 2002. Zhonghua Liu Xing Bing Xue Za Zhi. 2005, 26 (2): 77-83.PubMed Yang GH, Ma JM, Liu N, Zhou LN: Smoking and passive smoking in Chinese, 2002. Zhonghua Liu Xing Bing Xue Za Zhi. 2005, 26 (2): 77-83.PubMed
41.
go back to reference Capewell S: Predicting future coronary heart disease deaths in Finland and elsewhere. Int J Epid. 2006, 35: 1253-1254. 10.1093/ije/dyl158.CrossRef Capewell S: Predicting future coronary heart disease deaths in Finland and elsewhere. Int J Epid. 2006, 35: 1253-1254. 10.1093/ije/dyl158.CrossRef
42.
go back to reference Primatesta P, Brookes M, Poulter NR: Improved hypertension management and control. Results from the health survey for England 1998. Hypertension. 2001, 38: 827-832.PubMed Primatesta P, Brookes M, Poulter NR: Improved hypertension management and control. Results from the health survey for England 1998. Hypertension. 2001, 38: 827-832.PubMed
43.
go back to reference Grover SA, Gray-Donald K, Joseph L, Abrahamowicz M, Coupal L: Life expectancy following dietary modification or smoking cessation. Estimating the benefits of a prudent lifestyle. Arch Intern Med. 1994, 154: 1697-1704. 10.1001/archinte.154.15.1697.CrossRefPubMed Grover SA, Gray-Donald K, Joseph L, Abrahamowicz M, Coupal L: Life expectancy following dietary modification or smoking cessation. Estimating the benefits of a prudent lifestyle. Arch Intern Med. 1994, 154: 1697-1704. 10.1001/archinte.154.15.1697.CrossRefPubMed
44.
go back to reference Fichtenberg CM, Glantz SA: Association of the California Tobacco Control Program with declines in cigarette consumption and mortality from heart disease. N Engl J Med. 2000, 343: 1772-1777. 10.1056/NEJM200012143432406.CrossRefPubMed Fichtenberg CM, Glantz SA: Association of the California Tobacco Control Program with declines in cigarette consumption and mortality from heart disease. N Engl J Med. 2000, 343: 1772-1777. 10.1056/NEJM200012143432406.CrossRefPubMed
45.
go back to reference Critchley JA, Capewell S, Unal B: Life-years gained from coronary heart disease mortality reduction in Scotland: prevention or treatment?. J Clin Epidemiol. 2003, 56: 583-590. 10.1016/S0895-4356(03)00059-3.CrossRefPubMed Critchley JA, Capewell S, Unal B: Life-years gained from coronary heart disease mortality reduction in Scotland: prevention or treatment?. J Clin Epidemiol. 2003, 56: 583-590. 10.1016/S0895-4356(03)00059-3.CrossRefPubMed
46.
go back to reference Unal B, Critchley JA, Fidan D, Capewell S: Life-years gained from modern cardiological treatments and population risk factor changes in England and Wales, 1981–2000. Am J Public Health. 2005, 95: 103-108. 10.2105/AJPH.2003.029579.CrossRefPubMedPubMedCentral Unal B, Critchley JA, Fidan D, Capewell S: Life-years gained from modern cardiological treatments and population risk factor changes in England and Wales, 1981–2000. Am J Public Health. 2005, 95: 103-108. 10.2105/AJPH.2003.029579.CrossRefPubMedPubMedCentral
47.
go back to reference Schumacher MC, Hunt SC, Williams RR: Interactions between diabetes and family history of coronary heart disease and other risk factors for coronary heart disease among adults with diabetes in Utah. Epidemiology. 1990, 1: 298-304.CrossRefPubMed Schumacher MC, Hunt SC, Williams RR: Interactions between diabetes and family history of coronary heart disease and other risk factors for coronary heart disease among adults with diabetes in Utah. Epidemiology. 1990, 1: 298-304.CrossRefPubMed
48.
go back to reference Critchley JA, Capewell S: A systematic review of the mortality risk reduction when patients with coronary heart disease stop smoking. JAMA. 2003, 290: 86-97. 10.1001/jama.290.1.86.CrossRefPubMed Critchley JA, Capewell S: A systematic review of the mortality risk reduction when patients with coronary heart disease stop smoking. JAMA. 2003, 290: 86-97. 10.1001/jama.290.1.86.CrossRefPubMed
49.
go back to reference Zatonski WA, Willett W: Changes in dietary fat and declining coronary heart disease in Poland: population based study. BMJ. 2005, 331: 187-188. 10.1136/bmj.331.7510.187.CrossRefPubMedPubMedCentral Zatonski WA, Willett W: Changes in dietary fat and declining coronary heart disease in Poland: population based study. BMJ. 2005, 331: 187-188. 10.1136/bmj.331.7510.187.CrossRefPubMedPubMedCentral
50.
go back to reference Sargent RP, Shepard RM, Glantz SA: Reduced incidence of admissions for myocardial infarction associated with public smoking ban: before and after study. BMJ. 2004, 328: 977-980. 10.1136/bmj.38055.715683.55.CrossRefPubMedPubMedCentral Sargent RP, Shepard RM, Glantz SA: Reduced incidence of admissions for myocardial infarction associated with public smoking ban: before and after study. BMJ. 2004, 328: 977-980. 10.1136/bmj.38055.715683.55.CrossRefPubMedPubMedCentral
51.
go back to reference Bartecchi DC, Alsever RN, Nevin-Woods C, Thomas WM, Estacio RO, Bartelson BB, Krantz MJ: Reduction in the incidence of acute myocardial infarction associated with a citywide smoking ordinance. Circulation. 2006, 114: 1490-1496. 10.1161/CIRCULATIONAHA.106.615245.CrossRefPubMed Bartecchi DC, Alsever RN, Nevin-Woods C, Thomas WM, Estacio RO, Bartelson BB, Krantz MJ: Reduction in the incidence of acute myocardial infarction associated with a citywide smoking ordinance. Circulation. 2006, 114: 1490-1496. 10.1161/CIRCULATIONAHA.106.615245.CrossRefPubMed
52.
go back to reference Hoes AW, Grobbee DE, Valkenburg HA, Lubsen J, Hofman A: Cardiovascular risk and all-cause mortality; a 12 year follow-up study in the Netherlands. Eur J Epidemiol. 1993, 9: 285-292. 10.1007/BF00146265.CrossRefPubMed Hoes AW, Grobbee DE, Valkenburg HA, Lubsen J, Hofman A: Cardiovascular risk and all-cause mortality; a 12 year follow-up study in the Netherlands. Eur J Epidemiol. 1993, 9: 285-292. 10.1007/BF00146265.CrossRefPubMed
53.
go back to reference Tosteson AN, Weinstein MC, Williams LW, Goldman L: Long-term impact of smoking cessation on the incidence of coronary heart disease. Am J Public Health. 1990, 80: 1481-1486. 10.2105/AJPH.80.12.1481.CrossRefPubMedPubMedCentral Tosteson AN, Weinstein MC, Williams LW, Goldman L: Long-term impact of smoking cessation on the incidence of coronary heart disease. Am J Public Health. 1990, 80: 1481-1486. 10.2105/AJPH.80.12.1481.CrossRefPubMedPubMedCentral
54.
go back to reference Yang YM, Zhu J, Tan HQ, Liang Y, Zhang Y, Li JD, Liu LS, National Coordinator Office of CREATE in China: Clinical characteristics and management of patients with ST segment elevation myocardial infarction in China: survey of 7510 cases. Zhonghua Yi Xue Za Zhi. 2005, 85 (31): 2176-2182.PubMed Yang YM, Zhu J, Tan HQ, Liang Y, Zhang Y, Li JD, Liu LS, National Coordinator Office of CREATE in China: Clinical characteristics and management of patients with ST segment elevation myocardial infarction in China: survey of 7510 cases. Zhonghua Yi Xue Za Zhi. 2005, 85 (31): 2176-2182.PubMed
Metadata
Title
The impact of demographic and risk factor changes on coronary heart disease deaths in Beijing, 1999–2010
Authors
Jun Cheng
Dong Zhao
Zhechun Zeng
Julia Alison Critchley
Jing Liu
Wei Wang
Jiayi Sun
Simon Capewell
Publication date
01-12-2009
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2009
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-9-30

Other articles of this Issue 1/2009

BMC Public Health 1/2009 Go to the issue